Data from two prospective randomised adjuvant trials were combined to achieve a dataset of 1033 radically operated stage II and III CRC patients treated with either monthly 5FU and leucovorin ( LV ) as bolus injections ( Mayo or modified Mayo ) or bi-monthly with bolus and continuous infusion ( LV5FU2 or simplified LV5FU2 ) .